Signaling Pathways - MAGL - O6-methylguanine-DNA-methyl-transferase (MGMT) - p53-MDM2 interaction - Adenosine A2A Receptors
清除全部
-
B5904 Regadenoson1 Citation中文名: 类伽腺苷Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体激动剂 -
B6995 SCH 58261Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体竞争性拮抗剂 -
A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2抑制剂 -
A8454 Istradefylline (KW-6002)中文名: 伊曲茶碱Target: Adenosine A2A ReceptorsSummary: 选择性A2A受体拮抗剂 -
A2005 Nutlin-3bTarget: p53-MDM2 interactionSummary: MDM2/p53抑制剂 -
A3885 TozadenantTarget: Adenosine A2A ReceptorsSummary: 腺苷2A受体拮抗剂 -
A3735 PreladenantTarget: Adenosine A2A ReceptorsSummary: 腺苷A2A受体拮抗剂 -
A1912 Lomeguatrib中文名: 罗米鲁曲Target: O6-methylguanine-DNA-methyl-transferase (MGMT)Summary: MGMT抑制剂 -
N1846 Tanshinone IIA中文名: 丹参酮IIATarget: AP-1|MAGLSummary: 抗氧化和抗炎剂